Page 3 - Study Evaluating News Today

In January 2023, the FDA issued a new draft guidance document on optimizing the dosage of drugs and biological products for the treatment of...

17.01.2023 - SAN FRANCISCO and SAN DIEGO, Jan. 17, 2023 (GLOBE NEWSWIRE) - Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision oncology company, today announced the poster presentation of the design and rationale of a Phase 1 ... Seite 1

Post-hoc analysis of DISCOVER-2 Phase 3 data suggest active psoriatic arthritis patients with week 8 response to TREMFYA showed meaningful improvements in...

The rapid spread of influenza virus worldwide is driving the demand for the development of efficient influenza vaccine. Increasing clinical trials for new product development by market players

/PRNewswire/ -- DelveInsights Influenza Pipeline Insight 2022 report provides comprehensive global coverage of available, marketed, and pipeline influenza...

A randomized controlled trial showed that RenalGuard is no better than conventional IV hydration at preventing contrast-induced nephropathy in high-risk patients.

Gluten can be a nightmare for people who have digestive problems or are gluten intolerant. Here are 2023 best gluten-free protein powders.

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from Phase 3 studies demonstrating patients treated with...

The FDA issued the final guidance document for first-in-human trial designs that consist of both dose escalation as well as multiple expansion...

Data also discussed in context of OVX836 clinical development update presentation at 2022 World Vaccine Congress Osivax, a biopharmaceutical company developing vaccines to protect against highly